Daily non-political popular news in brief.

Novel MS drug shows promise in 2 lethal leukemias

A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.

Read more »

Keywords: novel, drug, shows, promise, lethal, leukemias, show, leukemia

« Previous | Next »

Similar news on "Novel MS drug shows promise in 2 lethal leukemias":

1. Novel drug preventing protein recycling shows potential for treating leukemia
   04-19-2007 · EurekAlert!
   Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.
   Similar news · Read more »
   
2. 'Modular' leukemia drug shows promise in early testing
   06-28-2007 · EurekAlert!
   A new type of engineered drug candidate has shown promise in treating chronic lymphocytic leukemia in both test tube and early animal tests, a new study shows. The agent represents a new class of agents called small modular immunopharmaceuticals. Called CD37-SMIP, the agent targets a protein called CD37 on the surface of these leukemia cells.
   Similar news · Read more »
   
3. Novel mechanism of action of new drug for MS identified
   10-11-2006 · EurekAlert!
   Virginia Commonwealth University researchers have identified a unique mechanism of action of a new drug that shows great promise for the treatment of multiple sclerosis.
   Similar news · Read more »
   
4. Targeting leukemic stem cells by Bcl-2 inhibition
   11-17-2006 · EurekAlert!
   Researchers at The University of Texas M. D. Anderson Cancer Center have found, in laboratory studies, that the experimental drug ABT-737 which has shown promise in some cancers, can destroy acute myeloid leukemia (AML) blast, progenitor and even stem cells that are often resistant to standard chemotherapy treatment.
   Similar news · Read more »
   
5. Breast cancer survival rates improved by novel drug sequence, say researchers
   02-12-2007 · EurekAlert!
   Changing the way women are treated for breast cancer could improve their overall chance of survival, according to research published today in the Lancet. The new paper shows that switching to a drug called exemestane, two to three years after commencing standard therapy with the drug tamoxifen, can cut the risk of death for certain women by a further 17 percent compared with using tamoxifen alone.
   Similar news · Read more »
   
6. Drug blocks lethal motor-neuron disease in mice
   02-22-2007 · EurekAlert!
   Spinal muscular atrophy (SMA) is a motor-neuron disease caused by mutations in the gene SMN1 that prevent it producing the protein SMN. New research shows that in a lethal mouse model of SMA the drug trichostatin A (TSA), which is a hydroxamic acid HDAC inhibitor, can improve survival and attenuate disease, indicating that hydroxamic acid HDAC inhibitors might be potential therapeutics for the treatment of individuals with SMA.
   Similar news · Read more »
   
7. Proteochemometrics achieves better retardants for HIV/Aids
   03-14-2007 · EurekAlert!
   A new method for analysis of retroviral proteins gives new opportunities to the development of novel retardants for HIV/Aids. The study, which was published in the March issue of PLoS Computational Biology, shows how to in a very exact way analyze the interaction of drug targets with small molecules.
   Similar news · Read more »
   
8. Drug and procedural interventions offer better quality of life
   03-26-2007 · EurekAlert!
   Emergency and nonemergency care of cardiovascular disease have continually improved over the past decade, thanks to improved quality of care, novel procedures and better therapies. Research on improved care of cardiovascular disease shows improvements with a combination of drug and risk factor interventions. Three studies presented today at the American College of Cardiology's 56th Annual Scientific Session assess how continued improvements in cardiac care can lead to enhanced clinical practice and improved quality of life.
   Similar news · Read more »
   
9. Study shows drug effective in treating, preventing breast cancer
   11-01-2007 · EurekAlert!
   A new study of an estrogen-derived drug shows promise as a treatment for breast cancer and breast cancer metastases to bone.
   Similar news · Read more »
   
10. Drug that interrupts a key stage of cell division shows promise for advanced solid tumors
    11-08-2006 · EurekAlert!
    One of the first studies to investigate the effects of a new anti-cancer drug in patients with advanced or metastatic solid tumours has shown that it is capable of halting progression of the disease, and the study has provided the first proof of the drug's mechanism of action, the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague was told on Wednesday.
    Similar news · Read more »